Functional outcome measures for NF1-associated optic pathway glioma clinical trials.
about
Optic glioma and precocious puberty in a girl with neurofibromatosis type 1 carrying an R681X mutation of NF1: case report and review of the literatureEliminating barriers to personalized medicine: learning from neurofibromatosis type 1Therapeutic advances for the tumors associated with neurofibromatosis type 1, type 2, and schwannomatosisIntra- and inter-visit reproducibility of ganglion cell-inner plexiform layer measurements using handheld optical coherence tomography in children with optic pathway gliomas.Neurofibromatosis-related tumors: emerging biology and therapies.Monoallelic loss of the imprinted gene Grb10 promotes tumor formation in irradiated Nf1+/- mice.Longitudinal Change of Circumpapillary Retinal Nerve Fiber Layer Thickness in Children With Optic Pathway GliomasImpact of vision loss among survivors of childhood central nervous system astroglial tumors.Whole Chromosome 7 Gain Predicts Higher Risk of Recurrence in Pediatric Pilocytic Astrocytomas Independently From KIAA1549-BRAF Fusion Status.Improving outcomes for neurofibromatosis 1-associated brain tumors.CNS Tumors in Neurofibromatosis.Orbital/Periorbital Plexiform Neurofibromas in Children with Neurofibromatosis Type 1: Multidisciplinary Recommendations for Care.Long-term visual outcomes of optic pathway gliomas in pediatric patients without neurofibromatosis type 1.Long-term visual outcome after chemotherapy for optic pathway glioma in children: Site and age are strongly predictive.Optic pathway glioma in children: does visual deficit correlate with radiology in focal exophytic lesions?Nerve growth factor improves visual loss in childhood optic gliomas: a randomized, double-blind, phase II clinical trial.Looking back to inform the future: Lesson learned from survivors of childhood cancer.Pediatric Low-Grade Gliomas: Next Biologically Driven Steps.Optic pathway glioma volume predicts retinal axon degeneration in neurofibromatosis type 1.Optic Pathway Gliomas in Neurofibromatosis Type 1.Neurofibromatosis type 1 and optic pathway glioma: Molecular interplay and therapeutic insights.Optical coherence tomography as a marker of vision in children with optic pathway gliomas.Cerebellar Hypoplasia and Dysmorphia in Neurofibromatosis Type 1.Defining the temporal course of murine neurofibromatosis-1 optic gliomagenesis reveals a therapeutic window to attenuate retinal dysfunction.Marked functional recovery and imaging response of refractory optic pathway glioma to BRAFV600E inhibitor therapy: a report of two cases.Genetically engineered minipigs model the major clinical features of human neurofibromatosis type 1
P2860
Q26775950-50E37065-6E42-43D3-87D5-CD4FEA854429Q26828988-4881E742-EF2E-4412-BDD1-278EB08036DEQ30357776-5A343238-2D38-4300-80E8-0813479A853AQ34603660-18D498DB-FB82-478B-9106-4D9E8AF860C5Q35218073-F5F20471-025E-4EE8-BFB7-EBA3592A2653Q35639252-6878E5D5-63AE-48F0-934D-6D5AE6E57DBEQ36322530-6F668868-E4BB-45D7-9CE0-28911856552CQ36609635-307DB7A4-CAFF-43CE-B289-2CCB26A87E81Q37228246-763B961E-10F7-40A3-876A-9D16751D9ACCQ38344456-8AC6B8FD-7ABB-4C0C-A258-04EFE34BB214Q38713914-8B91F016-ABC3-4EC1-BFFA-2A8105EC9E18Q39000307-135978D7-5B09-41F3-A6E7-4EA5950F30ACQ39677669-85C02D93-C305-4552-B675-AB4A91E04470Q40636040-E44131DA-AAA6-4558-B3B4-5074570949C4Q40639232-380A24CB-90CB-46BD-956E-8AEF82CC64ECQ40976967-028F98AC-26AE-42E7-AAEF-2E4F6B1F1C07Q46521197-7DF3F2FC-B8C0-4F64-9CF7-875D7134ADD4Q46667195-62A3BF16-6159-4969-8D31-D3EC8688483AQ46836518-4E305456-9F50-4A04-846D-70A73C6A300CQ47779215-BD019BDF-B736-4D2C-A1EB-9DFA08D223CBQ47887929-3917ACC1-C937-4F0D-A3ED-68C01D1D252FQ48170901-3BD601E4-04CB-4953-A2C8-BD25BE7D2514Q48302882-3F21F8D5-757F-445F-8165-C0A7DDBC00B1Q48376754-D889C303-522B-4C4E-8B2D-64068FA79092Q50215075-7497F56C-82E2-4523-82C1-82BAEBB2D046Q57298266-BFDBAAC1-D8FF-4D1A-ACD4-5394DFCF6F56
P2860
Functional outcome measures for NF1-associated optic pathway glioma clinical trials.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Functional outcome measures for NF1-associated optic pathway glioma clinical trials.
@en
Functional outcome measures for NF1-associated optic pathway glioma clinical trials.
@nl
type
label
Functional outcome measures for NF1-associated optic pathway glioma clinical trials.
@en
Functional outcome measures for NF1-associated optic pathway glioma clinical trials.
@nl
prefLabel
Functional outcome measures for NF1-associated optic pathway glioma clinical trials.
@en
Functional outcome measures for NF1-associated optic pathway glioma clinical trials.
@nl
P2093
P2860
P1433
P1476
Functional outcome measures for NF1-associated optic pathway glioma clinical trials.
@en
P2093
David H Gutmann
Grant T Liu
Larissa T Bilaniuk
Michael J Fisher
Nicole J Ullrich
REiNS International Collaboration
Robert A Avery
Robert Listernick
Simone L Ardern-Holmes
Staci Martin
P2860
P304
P356
10.1212/01.WNL.0000435745.95155.B8
P407
P433
21 Suppl 1
P577
2013-11-01T00:00:00Z